World Pharma News

World Pharma News is one of the world's leading web-based pharmaceutical news publications. Our subscribers are continuously informed about the latest and most prominent worldwide pharmaceutical news.

World Pharma News RSS Channel

Subscribe to World Pharma News by Email

Research & Development

More in: Research & Development

Conferences & Events

More in: Conferences & Events

GSK news

GlaxoSmithKline is a leading healthcare company that helps people to do more, feel better and live longer. This RSS feed contains press releases and investor news.

GSK further extends its product portfolio in the Middle East and North Africa
GSK today announced that it has acquired the branded generics business of Bristol Myers Squibb (BMS) in Lebanon, Jordan, Syria, Libya and Yemen for a cash consideration of $23.2m (£14.2m).
Seretide: Irish patent litigation update
GlaxoSmithKline (GSK) today announced that the Commercial Court in Dublin, Ireland, ruled in patent litigation regarding GSK?s product Seretide, an inhaled respiratory treatment for asthma and COPD.
GSK and Chroma Therapeutics form alliance to develop novel macrophage-targeted drugs
GlaxoSmithKline (LSE: GSK) and Chroma Therapeutics Limited announced today a collaboration to develop macrophage-targeted compounds using Chroma?s proprietary esterase-sensitive motif (ESM) technology, which adds amino acid esters to compounds with the aim of targeting the compounds to specific cells in the inflammatory disease process.
Regulatory update for REZONIC? (casopitant mesylate)
GlaxoSmithKline confirmed today that it has received a complete response letterfrom the FDA related to the application for casopitant.
FDA extends review of Arzerra? (ofatumumab)
GlaxoSmithKline and Genmab A/S today announced that the United States Food and Drug Administration (FDA) informed the companies that the agency has extended the action date for the ofatumumab BLA application by three months.
GSK announces a strategic alliance with Dr. Reddy?s to further accelerate sales growth in emerging markets
GlaxoSmithKline plc (GSK) today announced an agreement with Dr. Reddy?s Laboratories Ltd (Dr. Reddy?s) to develop and market selected products across an extensive number of emerging markets, excluding India.
GlaxoSmithKline update: A (H1N1) influenza
The World Health Organisation (WHO) has announced it has raised the current level of influenza pandemic alert from phase 5 to phase 6.
GSK and Shenzhen Neptunus create new alliance to develop and manufacture influenza vaccines in China
GSK today announced it has entered into a definitive agreement to form a new Joint Venture with Shenzhen Neptunus focused on developing and manufacturing influenza vaccines for the Chinese market.
Study shows GSK?s novel diabetes treatment Syncria® (albiglutide) improves glucose control and reduces weight
New Phase II data presented today at the American Diabetes Association 69th Scientific Sessions in New Orleans show that the investigational type 2 diabetes treatment Syncria® (albiglutide) significantly reduced blood glucose levels and provided weight loss across weekly, biweekly and monthly dosing.
Large, long-term study shows Avandia has no increased overall cardiovascular risk compared to other commonly used diabetes medicines
RECORD trial also demonstrates durable blood sugar control over time with Avandia